Stockreport

Tevogen Bio Announces Publication of Positive Phase I Clinical Trial Results for TVGN 489 in Blood Advances [Yahoo! Finance]

Tevogen Bio Holdings Inc.  (TVGN) 
PDF immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T cell therapeutics in oncology, neurology, and virology, reports publication of its phase [Read more]